Clinical phenotypes of Italian and Spanish patients with a1-antitrypsin deficiency Source: Eur Respir J 2013; 42: 54-64 Year: 2013
Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012
Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012
Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012
Clinical, functional, radiologic and quality of life characteristics in PI*SZ Alpha 1-Antitrypsin Deficiency (AATD) compared to PI*ZZ, PI*MZ and COPD without AATD: a retrospective cohort study. Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021
Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015
Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
Phase I safety investigation of an aerosolized, recombinant alpha 1-antitrypsin in subjects with alpha 1-antitrypsin deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 228s Year: 2004
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits Source: Eur Respir J, 50 (3) 1700198; 10.1183/13993003.00198-2017 Year: 2017
Alpha1-antitrypsin deficiency: An analysis of patient subgroups of the German registry Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Health status changes in patients with alpha-1-antitrypsin deficiency Source: Eur Respir J 2002; 20: Suppl. 38, 249s Year: 2002
The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database Source: Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016 Year: 2017
Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011
Pilot study for detection of alpha-1 antitrypsin deficiency in a targeted Argentinean population Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005
Molecular characterization of novel PiS-like alleles identified in Spanish patients with Alpha-1 antitrypsin deficiency Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018
Study of pulmonary function in children with homozygous beta thalassemia Source: Eur Respir J 2002; 20: Suppl. 38, 140s Year: 2002
Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020
Clinical considerations in individuals with a1 -antitrypsin PI*SZ genotype Source: Eur Respir J, 55 (6) 1902410; 10.1183/13993003.02410-2019 Year: 2020
Late Breaking Abstract - Impact of COVID-19 on patients with severe alpha1 antitrypsin deficiency: the IMCA1 study of the EARCO ERS Clinical Research Collaboration, preliminary findings. Source: Virtual Congress 2021 – Back to infection basics Year: 2021
Diagnosing alpha 1-antitrypsin deficiency: how to improve the current algorithm Source: Eur Respir Rev 2015; 24: 52-57 Year: 2015